Clinical White Papers and Case Studies

  1. Empowering Transformation Through Technology 4/24/2024

    By outlining the transformation of clinical data management into data science, this paper highlights the growing responsibility of data managers as stewards of all clinical trial data and its overall quality.

  2. Considerations For Plain Language Summaries 4/22/2024

    Recent FDA emphasis on plain language underscores a shift towards greater transparency and patient understanding, highlighted in the joint FDA and Office for Human Research Protections (OHRP) draft guidance.

  3. Efficient Data Aggregation & Oversight: A CRO Success Story 4/22/2024

    Explore how a full-service CRO & tech-driven life sciences provider streamlined data aggregation & clinical trial oversight, yielding significant time and cost savings.

  4. Consolidating Clinical Supply Chain Operations With GxP Inventory 4/18/2024

    A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.

  5. Optimizing Generative AI In Clinical Operations 4/17/2024

    Crafting a thoughtful strategy to determine the optimal utilization of Generative AI in advancing medical research and enhancing patient well-being.

  6. Patient-Defined Recruitment: The Movement Advanced By COVID-19 4/17/2024

    The pandemic forced the pharmaceutical industry to reimagine how we recruit patients to clinical trials – and it's delivering significant benefits to sponsors who embrace these changes.

  7. How Clinical Trial Design Impacts Enrollment Of Diverse Populations 4/17/2024

    Discover the latest findings revealing crucial insights into the factors influencing participants' engagement in clinical trials, offering valuable knowledge about the diverse perspectives and considerations driving participation decisions.

  8. Patient Engagement: Early Cancer Detection Blood Draw 4/17/2024

    Discover how we aided a pharmaceutical company in enrolling participants for a Phase III trial, DETECT-ASCEND 2, focused on Plasma-Based CancerSEEK Testing for early cancer detection.

  9. RTSM: Randomization And Cohort Management, IP Inventory Management 4/17/2024

    Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.

  10. Insights: Global Patient Views And Engagement In Clinical Trials 4/15/2024

    Enhancing the patient journey within clinical trials begins with engaging participants to understand their needs and preferences, ensuring they enroll and remain committed throughout the study.